Table 3.
2-year bioassay of Acrylamide |
Acrylamide (mM) | |||||
---|---|---|---|---|---|---|
0 | 0.0875 | 0.175 | 0.35 | 0.70 | ||
Males | ||||||
Retinal degeneration | 7/42d (17%)a* | 6/46 (13%) | 13/45 (29%) |
10/45 (22%) |
16/44 (36%)* |
|
Average severityb | 1.4 | 1.7 | 1.1 | 1.4 | 1.5 | |
Bilateral changec | 14% | 17% | 23% | 0% | 25% | |
Females | ||||||
Retinal degeneration | 16/44 (36%)* | 12/46 (26%) | 17/46 (37%) |
17/45 (38%) |
24/46 (52%) |
|
Average severity | 1.3 | 1.8 | 1.9 | 1.6 | 1.8 | |
Bilateral change | 19%* | 50% | 35% | 35% | 50%* |
: Frequency of retinal degeneration within all areas of the retina (central /hemispherical/peripheral)
: Average severity grade of lesions in affected eyes: 1 = mild, 2 = moderate, 3 = marked
: Rate of bilateral retinal degeneration in affected rats
: Fifty animals per group were initially assigned to each study however some animals were excluded from the assessment because of improper specimen handling, post mortem autolysis or due to early deaths.
Significant at *p < 0.05.
Trend test under control column; pairwise test under dose group columns.